nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—Chills—Ifosfamide—testicular cancer	0.00479	0.00479	CcSEcCtD
Cyproheptadine—Feeling abnormal—Chlorambucil—testicular cancer	0.00472	0.00472	CcSEcCtD
Cyproheptadine—Paraesthesia—Vinblastine—testicular cancer	0.00472	0.00472	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Etoposide—testicular cancer	0.0046	0.0046	CcSEcCtD
Cyproheptadine—Jaundice—Etoposide—testicular cancer	0.00458	0.00458	CcSEcCtD
Cyproheptadine—Decreased appetite—Vinblastine—testicular cancer	0.00457	0.00457	CcSEcCtD
Cyproheptadine—Urticaria—Chlorambucil—testicular cancer	0.00455	0.00455	CcSEcCtD
Cyproheptadine—Leukopenia—Dactinomycin—testicular cancer	0.00454	0.00454	CcSEcCtD
Cyproheptadine—Constipation—Vinblastine—testicular cancer	0.00449	0.00449	CcSEcCtD
Cyproheptadine—Confusional state—Bleomycin—testicular cancer	0.00447	0.00447	CcSEcCtD
Cyproheptadine—Oedema—Bleomycin—testicular cancer	0.00444	0.00444	CcSEcCtD
Cyproheptadine—Agranulocytosis—Etoposide—testicular cancer	0.00438	0.00438	CcSEcCtD
Cyproheptadine—Vision blurred—Ifosfamide—testicular cancer	0.00438	0.00438	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Bleomycin—testicular cancer	0.00434	0.00434	CcSEcCtD
Cyproheptadine—Feeling abnormal—Vinblastine—testicular cancer	0.00433	0.00433	CcSEcCtD
Cyproheptadine—Tinnitus—Cisplatin—testicular cancer	0.00429	0.00429	CcSEcCtD
Cyproheptadine—Agitation—Ifosfamide—testicular cancer	0.00427	0.00427	CcSEcCtD
Cyproheptadine—Anorexia—Bleomycin—testicular cancer	0.00423	0.00423	CcSEcCtD
Cyproheptadine—Vertigo—Ifosfamide—testicular cancer	0.00417	0.00417	CcSEcCtD
Cyproheptadine—Leukopenia—Ifosfamide—testicular cancer	0.00416	0.00416	CcSEcCtD
Cyproheptadine—Photosensitivity—Methotrexate—testicular cancer	0.00416	0.00416	CcSEcCtD
Cyproheptadine—Hypotension—Bleomycin—testicular cancer	0.00414	0.00414	CcSEcCtD
Cyproheptadine—Oedema—Dactinomycin—testicular cancer	0.00414	0.00414	CcSEcCtD
Cyproheptadine—Asthenia—Chlorambucil—testicular cancer	0.00411	0.00411	CcSEcCtD
Cyproheptadine—Palpitations—Ifosfamide—testicular cancer	0.0041	0.0041	CcSEcCtD
Cyproheptadine—Hepatic failure—Methotrexate—testicular cancer	0.00406	0.00406	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Dactinomycin—testicular cancer	0.00405	0.00405	CcSEcCtD
Cyproheptadine—Convulsion—Ifosfamide—testicular cancer	0.00402	0.00402	CcSEcCtD
Cyproheptadine—Paraesthesia—Bleomycin—testicular cancer	0.00398	0.00398	CcSEcCtD
Cyproheptadine—Anorexia—Dactinomycin—testicular cancer	0.00394	0.00394	CcSEcCtD
Cyproheptadine—Diarrhoea—Chlorambucil—testicular cancer	0.00392	0.00392	CcSEcCtD
Cyproheptadine—Photosensitivity—Epirubicin—testicular cancer	0.00389	0.00389	CcSEcCtD
Cyproheptadine—Decreased appetite—Bleomycin—testicular cancer	0.00386	0.00386	CcSEcCtD
Cyproheptadine—Confusional state—Ifosfamide—testicular cancer	0.00382	0.00382	CcSEcCtD
Cyproheptadine—Hepatic failure—Epirubicin—testicular cancer	0.0038	0.0038	CcSEcCtD
Cyproheptadine—Oedema—Ifosfamide—testicular cancer	0.00379	0.00379	CcSEcCtD
Cyproheptadine—Chills—Etoposide—testicular cancer	0.00378	0.00378	CcSEcCtD
Cyproheptadine—Vision blurred—Cisplatin—testicular cancer	0.00377	0.00377	CcSEcCtD
Cyproheptadine—Asthenia—Vinblastine—testicular cancer	0.00377	0.00377	CcSEcCtD
Cyproheptadine—Tremor—Cisplatin—testicular cancer	0.00375	0.00375	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Ifosfamide—testicular cancer	0.00371	0.00371	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Ifosfamide—testicular cancer	0.00366	0.00366	CcSEcCtD
Cyproheptadine—Feeling abnormal—Bleomycin—testicular cancer	0.00366	0.00366	CcSEcCtD
Cyproheptadine—Vomiting—Chlorambucil—testicular cancer	0.00364	0.00364	CcSEcCtD
Cyproheptadine—Increased appetite—Epirubicin—testicular cancer	0.00363	0.00363	CcSEcCtD
Cyproheptadine—Anorexia—Ifosfamide—testicular cancer	0.00361	0.00361	CcSEcCtD
Cyproheptadine—Photosensitivity—Doxorubicin—testicular cancer	0.0036	0.0036	CcSEcCtD
Cyproheptadine—Decreased appetite—Dactinomycin—testicular cancer	0.0036	0.0036	CcSEcCtD
Cyproheptadine—Diarrhoea—Vinblastine—testicular cancer	0.00359	0.00359	CcSEcCtD
Cyproheptadine—Leukopenia—Cisplatin—testicular cancer	0.00358	0.00358	CcSEcCtD
Cyproheptadine—Fatigue—Dactinomycin—testicular cancer	0.00357	0.00357	CcSEcCtD
Cyproheptadine—Hypotension—Ifosfamide—testicular cancer	0.00354	0.00354	CcSEcCtD
Cyproheptadine—Urticaria—Bleomycin—testicular cancer	0.00352	0.00352	CcSEcCtD
Cyproheptadine—Hepatic failure—Doxorubicin—testicular cancer	0.00352	0.00352	CcSEcCtD
Cyproheptadine—Irritability—Methotrexate—testicular cancer	0.00348	0.00348	CcSEcCtD
Cyproheptadine—Dizziness—Vinblastine—testicular cancer	0.00347	0.00347	CcSEcCtD
Cyproheptadine—Convulsion—Cisplatin—testicular cancer	0.00347	0.00347	CcSEcCtD
Cyproheptadine—Diplopia—Epirubicin—testicular cancer	0.00341	0.00341	CcSEcCtD
Cyproheptadine—Feeling abnormal—Dactinomycin—testicular cancer	0.00341	0.00341	CcSEcCtD
Cyproheptadine—Nausea—Chlorambucil—testicular cancer	0.0034	0.0034	CcSEcCtD
Cyproheptadine—Paraesthesia—Ifosfamide—testicular cancer	0.0034	0.0034	CcSEcCtD
Cyproheptadine—Somnolence—Ifosfamide—testicular cancer	0.00337	0.00337	CcSEcCtD
Cyproheptadine—Increased appetite—Doxorubicin—testicular cancer	0.00336	0.00336	CcSEcCtD
Cyproheptadine—Vomiting—Vinblastine—testicular cancer	0.00334	0.00334	CcSEcCtD
Cyproheptadine—Vertigo—Etoposide—testicular cancer	0.0033	0.0033	CcSEcCtD
Cyproheptadine—Decreased appetite—Ifosfamide—testicular cancer	0.0033	0.0033	CcSEcCtD
Cyproheptadine—Headache—Vinblastine—testicular cancer	0.00329	0.00329	CcSEcCtD
Cyproheptadine—Leukopenia—Etoposide—testicular cancer	0.00328	0.00328	CcSEcCtD
Cyproheptadine—Fatigue—Ifosfamide—testicular cancer	0.00327	0.00327	CcSEcCtD
Cyproheptadine—Oedema—Cisplatin—testicular cancer	0.00327	0.00327	CcSEcCtD
Cyproheptadine—Constipation—Ifosfamide—testicular cancer	0.00324	0.00324	CcSEcCtD
Cyproheptadine—Loss of consciousness—Etoposide—testicular cancer	0.00322	0.00322	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Cisplatin—testicular cancer	0.0032	0.0032	CcSEcCtD
Cyproheptadine—Tachycardia—Cisplatin—testicular cancer	0.00319	0.00319	CcSEcCtD
Cyproheptadine—Asthenia—Bleomycin—testicular cancer	0.00318	0.00318	CcSEcCtD
Cyproheptadine—Convulsion—Etoposide—testicular cancer	0.00318	0.00318	CcSEcCtD
Cyproheptadine—Diplopia—Doxorubicin—testicular cancer	0.00316	0.00316	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Cisplatin—testicular cancer	0.00316	0.00316	CcSEcCtD
Cyproheptadine—Feeling abnormal—Ifosfamide—testicular cancer	0.00312	0.00312	CcSEcCtD
Cyproheptadine—Nausea—Vinblastine—testicular cancer	0.00312	0.00312	CcSEcCtD
Cyproheptadine—Anorexia—Cisplatin—testicular cancer	0.00312	0.00312	CcSEcCtD
Cyproheptadine—Hypotension—Cisplatin—testicular cancer	0.00305	0.00305	CcSEcCtD
Cyproheptadine—Confusional state—Etoposide—testicular cancer	0.00302	0.00302	CcSEcCtD
Cyproheptadine—Urticaria—Ifosfamide—testicular cancer	0.00301	0.00301	CcSEcCtD
Cyproheptadine—Asthenia—Dactinomycin—testicular cancer	0.00297	0.00297	CcSEcCtD
Cyproheptadine—Paraesthesia—Cisplatin—testicular cancer	0.00293	0.00293	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Etoposide—testicular cancer	0.00293	0.00293	CcSEcCtD
Cyproheptadine—Tachycardia—Etoposide—testicular cancer	0.00292	0.00292	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Etoposide—testicular cancer	0.00289	0.00289	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Methotrexate—testicular cancer	0.00288	0.00288	CcSEcCtD
Cyproheptadine—Anorexia—Etoposide—testicular cancer	0.00285	0.00285	CcSEcCtD
Cyproheptadine—Decreased appetite—Cisplatin—testicular cancer	0.00284	0.00284	CcSEcCtD
Cyproheptadine—Diarrhoea—Dactinomycin—testicular cancer	0.00283	0.00283	CcSEcCtD
Cyproheptadine—Vomiting—Bleomycin—testicular cancer	0.00282	0.00282	CcSEcCtD
Cyproheptadine—Drowsiness—Methotrexate—testicular cancer	0.00281	0.00281	CcSEcCtD
Cyproheptadine—Hypotension—Etoposide—testicular cancer	0.0028	0.0028	CcSEcCtD
Cyproheptadine—Rash—Bleomycin—testicular cancer	0.0028	0.0028	CcSEcCtD
Cyproheptadine—Dermatitis—Bleomycin—testicular cancer	0.00279	0.00279	CcSEcCtD
Cyproheptadine—Pollakiuria—Epirubicin—testicular cancer	0.00273	0.00273	CcSEcCtD
Cyproheptadine—Asthenia—Ifosfamide—testicular cancer	0.00272	0.00272	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Epirubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Cyproheptadine—Feeling abnormal—Cisplatin—testicular cancer	0.00269	0.00269	CcSEcCtD
Cyproheptadine—Paraesthesia—Etoposide—testicular cancer	0.00269	0.00269	CcSEcCtD
Cyproheptadine—Weight increased—Epirubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Cyproheptadine—Somnolence—Etoposide—testicular cancer	0.00266	0.00266	CcSEcCtD
Cyproheptadine—Nausea—Bleomycin—testicular cancer	0.00263	0.00263	CcSEcCtD
Cyproheptadine—Drowsiness—Epirubicin—testicular cancer	0.00263	0.00263	CcSEcCtD
Cyproheptadine—Vomiting—Dactinomycin—testicular cancer	0.00263	0.00263	CcSEcCtD
Cyproheptadine—Agranulocytosis—Methotrexate—testicular cancer	0.00262	0.00262	CcSEcCtD
Cyproheptadine—Rash—Dactinomycin—testicular cancer	0.00261	0.00261	CcSEcCtD
Cyproheptadine—Decreased appetite—Etoposide—testicular cancer	0.0026	0.0026	CcSEcCtD
Cyproheptadine—Diarrhoea—Ifosfamide—testicular cancer	0.00259	0.00259	CcSEcCtD
Cyproheptadine—Fatigue—Etoposide—testicular cancer	0.00258	0.00258	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Epirubicin—testicular cancer	0.00258	0.00258	CcSEcCtD
Cyproheptadine—Jaundice—Epirubicin—testicular cancer	0.00256	0.00256	CcSEcCtD
Cyproheptadine—Constipation—Etoposide—testicular cancer	0.00256	0.00256	CcSEcCtD
Cyproheptadine—Hepatitis—Methotrexate—testicular cancer	0.00252	0.00252	CcSEcCtD
Cyproheptadine—Pollakiuria—Doxorubicin—testicular cancer	0.00252	0.00252	CcSEcCtD
Cyproheptadine—Dizziness—Ifosfamide—testicular cancer	0.00251	0.00251	CcSEcCtD
Cyproheptadine—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Cyproheptadine—Weight increased—Doxorubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Cyproheptadine—Feeling abnormal—Etoposide—testicular cancer	0.00247	0.00247	CcSEcCtD
Cyproheptadine—Nausea—Dactinomycin—testicular cancer	0.00246	0.00246	CcSEcCtD
Cyproheptadine—Agranulocytosis—Epirubicin—testicular cancer	0.00246	0.00246	CcSEcCtD
Cyproheptadine—Drowsiness—Doxorubicin—testicular cancer	0.00243	0.00243	CcSEcCtD
Cyproheptadine—Vomiting—Ifosfamide—testicular cancer	0.00241	0.00241	CcSEcCtD
Cyproheptadine—Rash—Ifosfamide—testicular cancer	0.00239	0.00239	CcSEcCtD
Cyproheptadine—Dermatitis—Ifosfamide—testicular cancer	0.00239	0.00239	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00239	0.00239	CcSEcCtD
Cyproheptadine—Urticaria—Etoposide—testicular cancer	0.00238	0.00238	CcSEcCtD
Cyproheptadine—Jaundice—Doxorubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Cyproheptadine—Hepatitis—Epirubicin—testicular cancer	0.00236	0.00236	CcSEcCtD
Cyproheptadine—Tinnitus—Methotrexate—testicular cancer	0.00235	0.00235	CcSEcCtD
Cyproheptadine—Asthenia—Cisplatin—testicular cancer	0.00234	0.00234	CcSEcCtD
Cyproheptadine—Agranulocytosis—Doxorubicin—testicular cancer	0.00227	0.00227	CcSEcCtD
Cyproheptadine—Chills—Methotrexate—testicular cancer	0.00226	0.00226	CcSEcCtD
Cyproheptadine—Nausea—Ifosfamide—testicular cancer	0.00225	0.00225	CcSEcCtD
Cyproheptadine—Diarrhoea—Cisplatin—testicular cancer	0.00224	0.00224	CcSEcCtD
Cyproheptadine—Tinnitus—Epirubicin—testicular cancer	0.0022	0.0022	CcSEcCtD
Cyproheptadine—Hepatitis—Doxorubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Cyproheptadine—Asthenia—Etoposide—testicular cancer	0.00215	0.00215	CcSEcCtD
Cyproheptadine—Chills—Epirubicin—testicular cancer	0.00212	0.00212	CcSEcCtD
Cyproheptadine—Vomiting—Cisplatin—testicular cancer	0.00208	0.00208	CcSEcCtD
Cyproheptadine—Vision blurred—Methotrexate—testicular cancer	0.00207	0.00207	CcSEcCtD
Cyproheptadine—Rash—Cisplatin—testicular cancer	0.00206	0.00206	CcSEcCtD
Cyproheptadine—Dermatitis—Cisplatin—testicular cancer	0.00206	0.00206	CcSEcCtD
Cyproheptadine—Diarrhoea—Etoposide—testicular cancer	0.00205	0.00205	CcSEcCtD
Cyproheptadine—Tinnitus—Doxorubicin—testicular cancer	0.00204	0.00204	CcSEcCtD
Cyproheptadine—Tension—Epirubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Cyproheptadine—Nervousness—Epirubicin—testicular cancer	0.002	0.002	CcSEcCtD
Cyproheptadine—Dizziness—Etoposide—testicular cancer	0.00198	0.00198	CcSEcCtD
Cyproheptadine—Vertigo—Methotrexate—testicular cancer	0.00197	0.00197	CcSEcCtD
Cyproheptadine—Leukopenia—Methotrexate—testicular cancer	0.00197	0.00197	CcSEcCtD
Cyproheptadine—Chills—Doxorubicin—testicular cancer	0.00196	0.00196	CcSEcCtD
Cyproheptadine—Nausea—Cisplatin—testicular cancer	0.00194	0.00194	CcSEcCtD
Cyproheptadine—Vision blurred—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Cyproheptadine—Convulsion—Methotrexate—testicular cancer	0.0019	0.0019	CcSEcCtD
Cyproheptadine—Vomiting—Etoposide—testicular cancer	0.0019	0.0019	CcSEcCtD
Cyproheptadine—Agitation—Epirubicin—testicular cancer	0.00189	0.00189	CcSEcCtD
Cyproheptadine—Rash—Etoposide—testicular cancer	0.00189	0.00189	CcSEcCtD
Cyproheptadine—Dermatitis—Etoposide—testicular cancer	0.00189	0.00189	CcSEcCtD
Cyproheptadine—Headache—Etoposide—testicular cancer	0.00188	0.00188	CcSEcCtD
Cyproheptadine—Tension—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Cyproheptadine—Nervousness—Doxorubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Cyproheptadine—Vertigo—Epirubicin—testicular cancer	0.00185	0.00185	CcSEcCtD
Cyproheptadine—Syncope—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Cyproheptadine—Leukopenia—Epirubicin—testicular cancer	0.00184	0.00184	CcSEcCtD
Cyproheptadine—Palpitations—Epirubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Cyproheptadine—Confusional state—Methotrexate—testicular cancer	0.00181	0.00181	CcSEcCtD
Cyproheptadine—Loss of consciousness—Epirubicin—testicular cancer	0.00181	0.00181	CcSEcCtD
Cyproheptadine—Vision blurred—Doxorubicin—testicular cancer	0.00179	0.00179	CcSEcCtD
Cyproheptadine—Convulsion—Epirubicin—testicular cancer	0.00178	0.00178	CcSEcCtD
Cyproheptadine—Nausea—Etoposide—testicular cancer	0.00178	0.00178	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Methotrexate—testicular cancer	0.00176	0.00176	CcSEcCtD
Cyproheptadine—Agitation—Doxorubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Methotrexate—testicular cancer	0.00173	0.00173	CcSEcCtD
Cyproheptadine—Vertigo—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Cyproheptadine—Anorexia—Methotrexate—testicular cancer	0.00171	0.00171	CcSEcCtD
Cyproheptadine—Syncope—Doxorubicin—testicular cancer	0.00171	0.00171	CcSEcCtD
Cyproheptadine—Leukopenia—Doxorubicin—testicular cancer	0.0017	0.0017	CcSEcCtD
Cyproheptadine—Confusional state—Epirubicin—testicular cancer	0.00169	0.00169	CcSEcCtD
Cyproheptadine—Palpitations—Doxorubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Cyproheptadine—Oedema—Epirubicin—testicular cancer	0.00168	0.00168	CcSEcCtD
Cyproheptadine—Hypotension—Methotrexate—testicular cancer	0.00168	0.00168	CcSEcCtD
Cyproheptadine—Loss of consciousness—Doxorubicin—testicular cancer	0.00167	0.00167	CcSEcCtD
Cyproheptadine—Shock—Epirubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Cyproheptadine—Convulsion—Doxorubicin—testicular cancer	0.00165	0.00165	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Cyproheptadine—Tachycardia—Epirubicin—testicular cancer	0.00164	0.00164	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Epirubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Cyproheptadine—Insomnia—Methotrexate—testicular cancer	0.00162	0.00162	CcSEcCtD
Cyproheptadine—Paraesthesia—Methotrexate—testicular cancer	0.00161	0.00161	CcSEcCtD
Cyproheptadine—Anorexia—Epirubicin—testicular cancer	0.0016	0.0016	CcSEcCtD
Cyproheptadine—Somnolence—Methotrexate—testicular cancer	0.00159	0.00159	CcSEcCtD
Cyproheptadine—Dyspepsia—Methotrexate—testicular cancer	0.00158	0.00158	CcSEcCtD
Cyproheptadine—Hypotension—Epirubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Cyproheptadine—Confusional state—Doxorubicin—testicular cancer	0.00157	0.00157	CcSEcCtD
Cyproheptadine—Decreased appetite—Methotrexate—testicular cancer	0.00156	0.00156	CcSEcCtD
Cyproheptadine—Oedema—Doxorubicin—testicular cancer	0.00155	0.00155	CcSEcCtD
Cyproheptadine—Fatigue—Methotrexate—testicular cancer	0.00155	0.00155	CcSEcCtD
Cyproheptadine—Shock—Doxorubicin—testicular cancer	0.00153	0.00153	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Cyproheptadine—Insomnia—Epirubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Cyproheptadine—Tachycardia—Doxorubicin—testicular cancer	0.00152	0.00152	CcSEcCtD
Cyproheptadine—Paraesthesia—Epirubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Doxorubicin—testicular cancer	0.0015	0.0015	CcSEcCtD
Cyproheptadine—Somnolence—Epirubicin—testicular cancer	0.00149	0.00149	CcSEcCtD
Cyproheptadine—Anorexia—Doxorubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Cyproheptadine—Feeling abnormal—Methotrexate—testicular cancer	0.00148	0.00148	CcSEcCtD
Cyproheptadine—Dyspepsia—Epirubicin—testicular cancer	0.00148	0.00148	CcSEcCtD
Cyproheptadine—Decreased appetite—Epirubicin—testicular cancer	0.00146	0.00146	CcSEcCtD
Cyproheptadine—Hypotension—Doxorubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Cyproheptadine—Fatigue—Epirubicin—testicular cancer	0.00145	0.00145	CcSEcCtD
Cyproheptadine—Constipation—Epirubicin—testicular cancer	0.00144	0.00144	CcSEcCtD
Cyproheptadine—Urticaria—Methotrexate—testicular cancer	0.00142	0.00142	CcSEcCtD
Cyproheptadine—Insomnia—Doxorubicin—testicular cancer	0.0014	0.0014	CcSEcCtD
Cyproheptadine—Paraesthesia—Doxorubicin—testicular cancer	0.00139	0.00139	CcSEcCtD
Cyproheptadine—Feeling abnormal—Epirubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Cyproheptadine—Somnolence—Doxorubicin—testicular cancer	0.00138	0.00138	CcSEcCtD
Cyproheptadine—Dyspepsia—Doxorubicin—testicular cancer	0.00137	0.00137	CcSEcCtD
Cyproheptadine—Decreased appetite—Doxorubicin—testicular cancer	0.00135	0.00135	CcSEcCtD
Cyproheptadine—Fatigue—Doxorubicin—testicular cancer	0.00134	0.00134	CcSEcCtD
Cyproheptadine—Urticaria—Epirubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Cyproheptadine—Constipation—Doxorubicin—testicular cancer	0.00133	0.00133	CcSEcCtD
Cyproheptadine—Asthenia—Methotrexate—testicular cancer	0.00129	0.00129	CcSEcCtD
Cyproheptadine—Feeling abnormal—Doxorubicin—testicular cancer	0.00128	0.00128	CcSEcCtD
Cyproheptadine—Urticaria—Doxorubicin—testicular cancer	0.00123	0.00123	CcSEcCtD
Cyproheptadine—Diarrhoea—Methotrexate—testicular cancer	0.00123	0.00123	CcSEcCtD
Cyproheptadine—Asthenia—Epirubicin—testicular cancer	0.0012	0.0012	CcSEcCtD
Cyproheptadine—Dizziness—Methotrexate—testicular cancer	0.00119	0.00119	CcSEcCtD
Cyproheptadine—Diarrhoea—Epirubicin—testicular cancer	0.00115	0.00115	CcSEcCtD
Cyproheptadine—Vomiting—Methotrexate—testicular cancer	0.00114	0.00114	CcSEcCtD
Cyproheptadine—Rash—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Cyproheptadine—Dermatitis—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Cyproheptadine—Headache—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Cyproheptadine—Asthenia—Doxorubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Cyproheptadine—Dizziness—Epirubicin—testicular cancer	0.00111	0.00111	CcSEcCtD
Cyproheptadine—Vomiting—Epirubicin—testicular cancer	0.00107	0.00107	CcSEcCtD
Cyproheptadine—Nausea—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Cyproheptadine—Diarrhoea—Doxorubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Cyproheptadine—Rash—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Cyproheptadine—Dermatitis—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Cyproheptadine—Headache—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Cyproheptadine—Dizziness—Doxorubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Cyproheptadine—Nausea—Epirubicin—testicular cancer	0.000997	0.000997	CcSEcCtD
Cyproheptadine—Vomiting—Doxorubicin—testicular cancer	0.000987	0.000987	CcSEcCtD
Cyproheptadine—Rash—Doxorubicin—testicular cancer	0.000979	0.000979	CcSEcCtD
Cyproheptadine—Dermatitis—Doxorubicin—testicular cancer	0.000978	0.000978	CcSEcCtD
Cyproheptadine—Headache—Doxorubicin—testicular cancer	0.000973	0.000973	CcSEcCtD
Cyproheptadine—Nausea—Doxorubicin—testicular cancer	0.000922	0.000922	CcSEcCtD
